Active Pharmaceutical Ingredient (API) Market Analysis by Type, Manufacturer, Origin, End Users (2020 – 2025)
Active Pharmaceutical Ingredient (API) Market Analysis by Type, Manufacturer, Origin, End Users (2020 – 2025)
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global active pharmaceutical ingredient (API) market generated revenue of US$ 161.4 billion in 2020 and is expected to reach US$ 211.0 billion by 2025 with a CAGR of 5.5% in the forecast period. Some of the major players in the active pharmaceutical ingredient (API) market are Mylan N.V., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Boehringer Ingelheim, Sanofi, Cipla, Inc., Api Pharma Tech, BDR Pharmaceuticals Internationals Pvt. Ltd., Sreepathi Pharmaceuticals Limited, Shilpa Medicare Limited.
The study offers a detailed analysis of the global market for active pharmaceutical ingredients (API). Considering 2019 as the base year, the report provides market information for the 2020 to 2025 forecast period. The study includes information on the current size and projected growth of the overall active pharmaceutical ingredient (API) market and its associated business segments. It outlines the dynamics, the business environment, and emerging developments in the active pharmaceutical ingredient (API) market.
The study contains a chapter that explains the impact of COVID 19 on the global active pharmaceutical ingredient (API) market. The study further discusses the key factors, the business environment, and emerging developments in the active pharmaceutical ingredient (API) market. The report will help several vendors to make the right investment and development decisions. The research focuses on the global active pharmaceutical ingredient (API) scenario and its proliferation across various market verticals. The descriptions in this report cover factors that currently influence and impede market growth and also accelerate the future dimensions of demand for the active pharmaceutical ingredient (API) market.
The chapters included in the report describe leading players in the active pharmaceutical ingredient (API) market. The study provides landscape analysis, which offers detailed profiles of major players in the active pharmaceutical ingredient (API) market worldwide. The report covers a fine-grained taxonomy of market segmentation in terms of type, manufacturer, origin, end-users.
Active Pharmaceutical Ingredient (API) Market, by Manufacturer
o Captive
o Merchant
o CMO
Active Pharmaceutical Ingredient (API) Market, by Origin
o Synthetic Active Pharmaceutical Ingredients
o Natural Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredient (API) Market, by End Users
o Clinical Trial
o Commercial
Active Pharmaceutical Ingredient (API) Market, by Region
o North America (U.S. Canada)
o Europe (Germany, U.K., France, Italy, Spain, Rest of Europe)
o Asia Pacific (China, Japan, India, Rest of Asia Pacific)
o Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa)
o Latin America (Brazil, Mexico, Rest of Latin America)
1. Introduction
2. Market Overview
2.1. Global Active Pharmaceutical Ingredient (API) Market Introduction
2.2. Macro- Economic Factor
2.3. Market Determinants
2.3.1. Market Driver
2.3.2. Market Restraints
2.3.3. Market Opportunities
2.3.4. Market Challenges
2.4. Technology/Product Roadmap
2.5. Market Growth Opportunity Analysis
3. Market Segmentation
3.1. Global Active Pharmaceutical Ingredient (API) Market Analysis (US$ Mn), By Manufacturer, 2019 – 2025
3.1.1. Captive
3.1.2. Merchant
3.1.3. CMO
3.2. Global Active Pharmaceutical Ingredient (API) Market Analysis (US$ Mn), By Origin, 2019 – 2025
3.2.1. Synthetic Active Pharmaceutical Ingredients
3.2.2. Natural Active Pharmaceutical Ingredients
3.3. Global Active Pharmaceutical Ingredient (API) Market Analysis (US$ Mn), By End Users, 2019 – 2025
3.3.1. Clinical Trial
3.3.2. Commercial
4. Regional Analysis
4.1. North America Active Pharmaceutical Ingredient (API) Market Analysis (US$ Mn), 2019 - 2025
4.1.1. By Country
4.1.1.1. U.S.
4.1.1.2. Canada
4.1.2. By Manufacturer
4.1.2.1. Captive
4.1.2.2. Merchant
4.1.2.3. CMO
4.1.3. By Origin
4.1.3.1. Synthetic Active Pharmaceutical Ingredients
4.1.3.2. Natural Active Pharmaceutical Ingredients
4.1.4. By End Users
4.1.4.1. Clinical Trial
4.1.4.2. Commercial
4.2. Europe Active Pharmaceutical Ingredient (API) Market Analysis (US$ Mn), 2019 - 2025
4.2.1. By Country, 2019 – 2025
4.2.1.1. Germany
4.2.1.2. U.K.
4.2.1.3. France
4.2.1.4. Italy
4.2.1.5. Spain
4.2.1.6. Rest of Europe
4.2.2. By Manufacturer
4.2.2.1. Captive
4.2.2.2. Merchant
4.2.2.3. CMO
4.2.3. By Origin
4.2.3.1. Synthetic Active Pharmaceutical Ingredients
4.2.3.2. Natural Active Pharmaceutical Ingredients
4.2.4. By End Users
4.2.4.1. Clinical Trial
4.2.4.2. Commercial
4.3. Asia Pacific Active Pharmaceutical Ingredient (API) Market Analysis (US$ Mn), 2019 - 2025
4.3.1. By Country, 2019 – 2025
4.3.1.1. China
4.3.1.2. Japan
4.3.1.3. India
4.3.1.4. Rest of Asia Pacific
4.3.2. By Manufacturer
4.3.2.1. Captive
4.3.2.2. Merchant
4.3.2.3. CMO
4.3.3. By Origin
4.3.3.1. Synthetic Active Pharmaceutical Ingredients
4.3.3.2. Natural Active Pharmaceutical Ingredients
4.3.4. By End Users
4.3.4.1. Clinical Trial
4.3.4.2. Commercial
4.4. Middle East & Africa Active Pharmaceutical Ingredient (API) Market Analysis (US$ Mn), 2019 - 2025
4.4.1. By Country, 2019 – 2025
4.4.1.1. GCC
4.4.1.2. South Africa
4.4.1.3. Rest of Middle East & Africa
4.4.2. By Manufacturer
4.4.2.1. Captive
4.4.2.2. Merchant
4.4.2.3. CMO
4.4.3. By Origin
4.4.3.1. Synthetic Active Pharmaceutical Ingredients
4.4.3.2. Natural Active Pharmaceutical Ingredients
4.4.4. By End Users
4.4.4.1. Clinical Trial
4.4.4.2. Commercial
4.5. Latin America Active Pharmaceutical Ingredient (API) Market Analysis (US$ Mn), 2019 - 2025
4.5.1. By Country, 2019 – 2025
4.5.1.1. Brazil
4.5.1.2. Mexico
4.5.1.3. Rest of Latin America
4.5.2. By Manufacturer
4.5.2.1. Captive
4.5.2.2. Merchant
4.5.2.3. CMO
4.5.3. By Origin
4.5.3.1. Synthetic Active Pharmaceutical Ingredients
4.5.3.2. Natural Active Pharmaceutical Ingredients
4.5.4. By End Users
4.5.4.1. Clinical Trial
4.5.4.2. Commercial
5. Competitive Analysis
5.1. Company Share Analysis (%) 2019
5.2. List of Acquisition, Merger, Collaboration & New Product Launch
6. Company Profiles
6.1. Mylan N.V.
6.2. Teva Pharmaceutical Industries Ltd.
6.3. Pfizer, Inc.
6.4. Boehringer Ingelheim
6.5. Sanofi
6.6. Cipla, Inc.
6.7. Api Pharma Tech
6.8. BDR Pharmaceuticals Internationals Pvt. Ltd.
6.9. Sreepathi Pharmaceuticals Limited
6.10. Shilpa Medicare Limited.
Research Methodology:
Active Pharmaceutical Ingredient (API) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|